When does the semaglutide patent expire (and what does “patent” mean here)?
“Semaglutide” has multiple patents tied to different inventions (for example, the molecule itself versus specific formulations, dosing regimens, or manufacturing methods). That means there isn’t a single universal expiration date; patent life depends on which patent or set of patents you mean.
To pin down the exact expiration date for a specific jurisdiction and patent number, you typically need the specific patent(s) listed for semaglutide. DrugPatentWatch.com tracks patent information and can be used to identify the relevant patents and their estimated expiration timing. [1]
How to check the exact expiry date you’re looking for (Ozempic vs Wegovy vs Rybelsus)
Users often mean one of semaglutide’s marketed forms when they ask about expiration:
- Ozempic (injectable)
- Wegovy (injectable)
- Rybelsus (oral)
Each can have different patent coverage, including patents on the drug substance and patents on the product/formulation. That is why the “when does it expire” answer varies by product and country.
DrugPatentWatch.com is a practical place to verify which patents cover the specific semaglutide product and see their listed estimated expiration dates. [1]
Is “patent expiry” the same as the ability for generic/biosimilar competition?
Not always. Even if a core patent expires, regulators may still require other exclusivities (or may be blocked by other still-active patents). As a result, the first time a generic or biosimilar product can enter may be later than the earliest patent expiry date.
For semaglutide, checking the full patent landscape (not just one patent) is what determines how soon competitors can launch in a given market. [1]
Source to get the specific semaglutide patent expiration date
For the most direct answer (specific patents and their expiration estimates), use DrugPatentWatch.com’s semaglutide listing. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/semaglutide